Author:
Utsunomiya Masako,Dobashi Hiroaki,Odani Toshio,Saito Kazuyoshi,Yokogawa Naoto,Nagasaka Kenji,Takenaka Kenchi,Soejima Makoto,Sugihara Takahiko,Hagiyama Hiroyuki,Hirata Shinya,Matsui Kazuo,Nonomura Yoshinori,Kondo Masahiro,Suzuki Fumihito,Tomita Makoto,Kihara Mari,Yokoyama Waka,Hirano Fumio,Yamazaki Hayato,Sakai Ryoko,Nanki Toshihiro,Koike Ryuji,Kohsaka Hitoshi,Miyasaka Nobuyuki,Harigai Masayoshi
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Thomas CFJ, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350:2487–98.
2. Thomas CFJ, Limper AH. Current insights into the biology and pathogenesis of Pneumocystis pneumonia. Nat Rev Microbiol. 2007;5:298–308.
3. Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR Recomm Rep. 1992;41:1–11.
4. Sepkowitz KA, Brown AE, Armstrong D. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk. Arch Intern Med. 1995;155:1125–8.
5. Hughes WT, Feldman S, Aur RJA, Verzosa MS, Hustu HO, Simone JV. Intensity of immunosuppressive therapy and the incidence of pneumocystis carinii pneumonitis. Cancer. 1975;36:2004–9.